BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1580116)

  • 1. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
    DiBonito L; Falconieri G; Colautti I; Bonifacio D; Dudine S
    Acta Cytol; 1992; 36(3):329-32. PubMed ID: 1580116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
    DiBonito L; Falconieri G; Colautti I; Bonifacio D; Dudine S
    Acta Cytol; 1993; 37(4):483-8. PubMed ID: 8328242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The usefulness of pleural biopsy in benign or malignant pleurisy].
    Inoue Y; Miura N; Watanabe T; Watanabe K; Tsutsumi T; Doutsu Y; Kohno S; Kanda T; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):332-7. PubMed ID: 2067153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India.
    Awasthi A; Gupta N; Srinivasan R; Nijhawan R; Rajwanshi A
    Cytopathology; 2007 Feb; 18(1):28-32. PubMed ID: 17250600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions.
    Renshaw AA; Nappi D; Cibas ES
    Diagn Cytopathol; 1996 Aug; 15(2):103-7. PubMed ID: 8872430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
    Cakir E; Demirag F; Aydin M; Unsal E
    Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions.
    Chi DS; Abu-Rustum NR; Sonoda Y; Chen SW; Flores RM; Downey R; Aghajanian C; Barakat RR
    Gynecol Oncol; 2004 Aug; 94(2):307-11. PubMed ID: 15297166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural effusions. A clinical cytopathologic study.
    Irani DR; Underwood RD; Johnson EH; Greenberg SD
    Arch Intern Med; 1987 Jun; 147(6):1133-6. PubMed ID: 3592878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of pleural fluid data in patients with malignant effusion.
    Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
    Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
    Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
    Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of malignant pleural effusion by pleurodesis with talc].
    Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
    Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?
    Brock MV; Hooker CM; Yung R; Guo M; Han Y; Ames SE; Chang D; Yang SC; Mason D; Sussman M; Baylin SB; Herman JG
    Ann Thorac Surg; 2005 Oct; 80(4):1241-7. PubMed ID: 16181847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.